The significance of technological and scientific advancements in medicine is unquestionable. However, it prompts a critical examination of the appropriate limits when conducting experiments to uncover treatments leading to optimal outcomes. Experimentation necessarily entails risks, and achieving medical progress often involves interventions with potential dangers and unknown outcomes. Striking the right balance between advancing medical knowledge through experimental procedures and the imperative to safeguard patient health is a complex challenge. Ethical considerations must guide the pursuit of innovation to ensure that progress is achieved responsibly and with due regard for the well-being of patients.
In this bonus episode for premium subscribers, Dr. Eithan Haim draws a compelling distinction between the therapeutic justification underpinning effective life-saving medical treatments which may exhibit high mortality rates during their experimental phases. He cites the Left Ventricular Assist Device (LVAD) as a prime example of this. In his analysis, he contrasts these kinds of successful interventions with historical medical practices like bloodletting and lobotomies, which proved unsuccessful in addressing psychological issues through physiological solutions. He highlights parallels to in gender medicine, expressing reservations about the potential consequences of misguided medical interventions.
Watch our full length episode with Dr. Eithan Haim:
Listen to this episode with a 7-day free trial
Subscribe to Gender: A Wider Lens to listen to this post and get 7 days of free access to the full post archives.
